A venture capital fund located in Montreal focused on creating promising life science companies.
Business Model:
Revenue: $13.1M
Employees: 11-50
Address: 1 Westmount Square,
City: Montreal
State: quebec
Zip: H3Z 2P9
Country: CA
AmorChem l.p., our fourth focused fund, was launched in 2011 to increase the commercial potential of the quality academic research carried out in Quebec. AmorChem is focused on investing in promising life science projects originating from Québec-based universities and research centres. AmorChem’s innovative business model involves financing research-stage projects to enable them to reach pre-clinical proof-of-concept in a semi-virtual mode. AmorChem will generate returns through a two-pronged exit strategy:
Contact Phone:
+15148497696
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2022 | Inversago Pharma | Series C | 0 |
5/2021 | Giiant Pharma | Seed Round | 0 |
9/2020 | Inversago Pharma | Series B | 0 |
7/2018 | Inversago Pharma | Series A | 0 |
3/2018 | Semathera | Venture Round | 2.6M |
9/2017 | SpecificiT Pharma | Seed Round | - |
5/2021 | Giiant Pharma | Seed Round | 0 |
9/2020 | Inversago Pharma | Series B | 0 |
7/2018 | Inversago Pharma | Series A | 0 |
3/2018 | Semathera | Venture Round | 0 |
9/2017 | SpecificiT Pharma | Seed Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|